P903: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE IN NEWLY DIAGNOSED PATIENTS WITH MAYO 2004 STAGE 3 LIGHT-CHAIN AMYLOIDOSIS: A PROSPECTIVE PHASE 2 STUDY
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000846484.91738.d2 |
| _version_ | 1827336833171718144 |
|---|---|
| author | Y.-J. Gao K.-N. Shen L. Chang J. Feng L. Zhang Y.-Y. Mao X.-X. Cao D.-B. Zhou J. Li |
| author_facet | Y.-J. Gao K.-N. Shen L. Chang J. Feng L. Zhang Y.-Y. Mao X.-X. Cao D.-B. Zhou J. Li |
| author_sort | Y.-J. Gao |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:41:13Z |
| format | Article |
| id | doaj.art-1fcb466eb2ee4f319ab28b207789f2fd |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:41:13Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-1fcb466eb2ee4f319ab28b207789f2fd2024-03-02T03:51:54ZengWileyHemaSphere2572-92412022-06-01679479510.1097/01.HS9.0000846484.91738.d2202206003-00794P903: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE IN NEWLY DIAGNOSED PATIENTS WITH MAYO 2004 STAGE 3 LIGHT-CHAIN AMYLOIDOSIS: A PROSPECTIVE PHASE 2 STUDYY.-J. Gao0K.-N. Shen1L. Chang2J. Feng3L. Zhang4Y.-Y. Mao5X.-X. Cao6D.-B. Zhou7J. Li81 Department of Hematology, Peking Union Medical College Hospital, Beijing, China1 Department of Hematology, Peking Union Medical College Hospital, Beijing, China1 Department of Hematology, Peking Union Medical College Hospital, Beijing, China1 Department of Hematology, Peking Union Medical College Hospital, Beijing, China1 Department of Hematology, Peking Union Medical College Hospital, Beijing, China1 Department of Hematology, Peking Union Medical College Hospital, Beijing, China1 Department of Hematology, Peking Union Medical College Hospital, Beijing, China1 Department of Hematology, Peking Union Medical College Hospital, Beijing, China1 Department of Hematology, Peking Union Medical College Hospital, Beijing, Chinahttp://journals.lww.com/10.1097/01.HS9.0000846484.91738.d2 |
| spellingShingle | Y.-J. Gao K.-N. Shen L. Chang J. Feng L. Zhang Y.-Y. Mao X.-X. Cao D.-B. Zhou J. Li P903: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE IN NEWLY DIAGNOSED PATIENTS WITH MAYO 2004 STAGE 3 LIGHT-CHAIN AMYLOIDOSIS: A PROSPECTIVE PHASE 2 STUDY HemaSphere |
| title | P903: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE IN NEWLY DIAGNOSED PATIENTS WITH MAYO 2004 STAGE 3 LIGHT-CHAIN AMYLOIDOSIS: A PROSPECTIVE PHASE 2 STUDY |
| title_full | P903: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE IN NEWLY DIAGNOSED PATIENTS WITH MAYO 2004 STAGE 3 LIGHT-CHAIN AMYLOIDOSIS: A PROSPECTIVE PHASE 2 STUDY |
| title_fullStr | P903: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE IN NEWLY DIAGNOSED PATIENTS WITH MAYO 2004 STAGE 3 LIGHT-CHAIN AMYLOIDOSIS: A PROSPECTIVE PHASE 2 STUDY |
| title_full_unstemmed | P903: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE IN NEWLY DIAGNOSED PATIENTS WITH MAYO 2004 STAGE 3 LIGHT-CHAIN AMYLOIDOSIS: A PROSPECTIVE PHASE 2 STUDY |
| title_short | P903: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE IN NEWLY DIAGNOSED PATIENTS WITH MAYO 2004 STAGE 3 LIGHT-CHAIN AMYLOIDOSIS: A PROSPECTIVE PHASE 2 STUDY |
| title_sort | p903 daratumumab plus bortezomib and dexamethasone in newly diagnosed patients with mayo 2004 stage 3 light chain amyloidosis a prospective phase 2 study |
| url | http://journals.lww.com/10.1097/01.HS9.0000846484.91738.d2 |
| work_keys_str_mv | AT yjgao p903daratumumabplusbortezomibanddexamethasoneinnewlydiagnosedpatientswithmayo2004stage3lightchainamyloidosisaprospectivephase2study AT knshen p903daratumumabplusbortezomibanddexamethasoneinnewlydiagnosedpatientswithmayo2004stage3lightchainamyloidosisaprospectivephase2study AT lchang p903daratumumabplusbortezomibanddexamethasoneinnewlydiagnosedpatientswithmayo2004stage3lightchainamyloidosisaprospectivephase2study AT jfeng p903daratumumabplusbortezomibanddexamethasoneinnewlydiagnosedpatientswithmayo2004stage3lightchainamyloidosisaprospectivephase2study AT lzhang p903daratumumabplusbortezomibanddexamethasoneinnewlydiagnosedpatientswithmayo2004stage3lightchainamyloidosisaprospectivephase2study AT yymao p903daratumumabplusbortezomibanddexamethasoneinnewlydiagnosedpatientswithmayo2004stage3lightchainamyloidosisaprospectivephase2study AT xxcao p903daratumumabplusbortezomibanddexamethasoneinnewlydiagnosedpatientswithmayo2004stage3lightchainamyloidosisaprospectivephase2study AT dbzhou p903daratumumabplusbortezomibanddexamethasoneinnewlydiagnosedpatientswithmayo2004stage3lightchainamyloidosisaprospectivephase2study AT jli p903daratumumabplusbortezomibanddexamethasoneinnewlydiagnosedpatientswithmayo2004stage3lightchainamyloidosisaprospectivephase2study |